AI is revolutionising cancer diagnosis with new methods. How will innovations like AIDA impact accuracy and adaptability?

Inflammation and genetic mutations can drive cardiovascular complications in patients with myeloproliferative neoplasms, which include disorders such as polycythemia vera, essential thrombocythemia, ...

By Pooja Toshniwal Paharia New AI-driven tool converts common histology images into detailed, multi-layered cancer markers, ...

Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker for predicting efficacy of Nivolumab plus Chemotherapy in advanced gastric cancer, independent of PD-L1 ...

Stratipath Breast risk stratifies breast cancer by analyzing digitized histopathology slides of breast cancer tissue.

A recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of ...